Partneringdesk Deals and Alliances In Oncology

Report summary Partneringdesk deals and alliances in oncology provides an in-depth view of over 2100 deals and alliances announced in oncology between 2001 and 2006, in a clear and accessible PDF format. Reasons to purchase (USPs and key questions answered): Partneringdesk Deals and alliances in oncology provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment of deal-making trends in the last five years identifying active partners tracking competitor activity benchmarking deals Methodology This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources. Report scope The report contains: fully categorized deal overviews financial information where disclosed company profiles of the top 25 dealmakers in the report specialized indexes by company, development stage, deal type and industry sector. wider coverage of Japanese deals courtesy of JCN Forecasts, projections, market estimates This report provides a series of charts with analyses detailing market trends in oncology deal making over the period of 2001 to 2006.

Additional Information

Who should buy the report
This report is essential reading for board and executive management, and individuals in:

• business development
• licensing/partnering
• deal making
• business strategy
• marketing and promotion
• distribution and manufacturing (including contract services).

The report includes profiles from the following companies active in oncology:
Abbott Laboratories
Abgenix
AstraZeneca
Cancer Research Technology
Celgene
Corixa
Cytyc
Elan
Elekta
Genentech
GlaxoSmithKline
Hologic
ImmunoGen
Kirin Brewery
MD Anderson Cancer Center
Medarex
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals
National Cancer Institute
National Institutes of Health
R2 Technology
Roche
Seattle Genetics
TriPath Imaging
Viragen